Avanza Pharma Announces the Launch of "Specials" Supply for the UK Market
St. Albans, United Kingdom, November 23, 2015 (Newswire.com) - Avanza Pharma Ltd announces the launch of a range of specialty products for next day delivery to hospital and retail pharmacy customers in the UK and for export.
With over 6,000 formulations available in different dosage forms, including:
- Liquids: Oral Solutions, Suspensions and Topical Liquids
- Semi-solids: Creams, Ointments, Gels and Suppositories and Pessaries
- Solid dose: Hard Gelatine Capsules, Powders and Gelatine Free Capsules
- Drops: Ear, Eyes, Nasal
- Coal tar products
Avanza Pharma are committed to the manufacture of high quality medicines, continually reviewing the product range to ensure they meet specialist requirements.
Price is kept low and transparent and with no delivery charge; delivering value for money to hospital and retail pharmacy customers.
About Specials
Specials are unlicensed medicines, manufactured to meet the needs of an individual patient when there is no suitable licensed drug available or their conditions are relatively rare. Unlicensed medicines may be prescribed in clinical situations where on the basis of available evidence, their use is in the best interest of the patient. Patients who receive Specials may not be able to take the normal, licensed medicine because they are allergic to an ingredient, or may need the formulation in liquid form because they cannot swallow a tablet.
NHS spending on Specials in England in 2013 was over £100 million, representing just over 1% of the total NHS prescription spend in England (£8.6 billion). In recent years, with pressure on NHS budgets, the cost of Specials has come under scrutiny.
About Avanza Pharma
Avanza Pharma is a privately owned pharmaceutical company specializing in the manufacture, supply and licensing of specialty products, with a specific emphasis on oral liquids for growing paediatric and geriatric conditions. Founded in 2014 and based in the UK, we are committed to value for money, service excellence and quality for the patient.
